Image-based Mapping of Brain Tumors

Overview

About this study

The purpose of this study is to combine MRI images with histologic and genetic analysis of cancer (from blood and tissue samples) to improve the overall accuracy of diagnosis and effectiveness of cancer treatment.

 

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria

  • Prospective collection
    • Undergoing diagnostic biopsy and/or surgical resection for brain tumor
  • Retrospective collection
    • Underwent treatment and/or diagnosis for suspected brain tumor

Exclusion Criteria

  • Prospective collection only
    • Unable to have an MRI

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 4/8/2024. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Leland Hu, M.D.

Open for enrollment

Contact information:

Maritza Grijalva

(480) 574-2797

Grijalva.Maritza@mayo.edu

Rochester, Minn.

Mayo Clinic principal investigator

Leland Hu, M.D.

Closed for enrollment

Contact information:

No Contact

More information

Publications

Publications are currently not available

Additional contact information

Cancer-related trials contact form

Phone: 855-776-0015 (toll-free)

International patient clinical studies questions